Skip to main content Skip to section navigation Skip to footer
  • About
    • Discover Mineralys
    • Purpose & Values
    • Our Team
  • Science
    • Lorundrostat
    • Aldosterone
    • Hypertension
    • Cardio-Renal-Metabolic Syndrome
  • Pipeline
  • Investors
  • Publications
  • Contact Us
    • Careers & Culture
    • Partnering
    • Contact Form
Menu
  • About
    • Discover Mineralys
    • Purpose & Values
    • Our Team
  • Science
    • Lorundrostat
    • Aldosterone
    • Hypertension
    • Cardio-Renal-Metabolic Syndrome
  • Pipeline
  • Investors
  • Publications
  • Contact Us
    • Careers & Culture
    • Partnering
    • Contact Form

Press Releases

Investors

Investors

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Presentations
    • Email Alerts
  • SEC Filings
    • All SEC Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
    • Board Diversity Matrix
  • News & Events

  • Overview
  • Press Releases
  • IR Calendar
  • Presentations
  • Email Alerts
Oct 22, 2024 8:00 am EDT

Mineralys to Host Virtual KOL Event on the Unmet Medical Need in Uncontrolled and Resistant Hypertension, and Lorundrostat as a Potential Treatment on October 30, 2024

Sep 25, 2024 8:00 am EDT

Mineralys Therapeutics Completes Target Enrollment in Pivotal Advance-HTN Trial of Lorundrostat for the Treatment of Hypertension

Aug 28, 2024 8:00 am EDT

Mineralys Therapeutics to Participate in the Wells Fargo Healthcare Conference

Aug 13, 2024 4:05 pm EDT

Mineralys Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update

Aug 05, 2024 4:05 pm EDT

Mineralys Therapeutics to Announce Second Quarter 2024 Financial Results and Host Conference Call on Tuesday, August 13, 2024

Jun 14, 2024 8:00 am EDT

Mineralys Therapeutics Appoints Biopharmaceutical Executive Alexander M. Gold, M.D. to its Board of Directors

Jun 03, 2024 8:00 am EDT

Mineralys Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

May 09, 2024 7:00 am EDT

Mineralys Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update

May 06, 2024 8:00 am EDT

Mineralys Therapeutics to Participate in the Bank of America Securities Health Care Conference

May 02, 2024 8:00 am EDT

Mineralys Therapeutics to Announce First Quarter 2024 Financial Results and Host Conference Call on Thursday, May 9, 2024

  • Previous Pagearrow_back
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Next Pagearrow_forward
rss_feed News RSS
  • Email Alerts
  • Contacts
  • RSS News Feed
© 2025 Mineralys Therapeutics, LLC
  • Terms & Conditions
  • Privacy Policy
  • X/Twitter Icon Twitter
  • Linkedin